In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
- Latest Posts
Best in Biotech 30 May 2024
Stem cell therapy’s avant-garde: Eight companies leading the way
Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.
Best in Biotech 28 May 2024
8 Swedish companies spearheading the country’s biotech scene
As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.
More News! 27 May 2024
New report shows that Swiss biotech capital investment surged last year
With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024.
Expert Advice 24 May 2024
Mission statement, the key to success for biotech companies
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
ADVERTISEMENT
ADVERTISEMENT
In Depth 23 May 2024
Is prime editing ready for prime time?
Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
Best in Biotech 23 May 2024
10 notable pharma and biotech venture capital arms
Discover 10 big pharma and biotech companies that have spun out their own venture capital arms to invest in startups in the industry.
In Depth 22 May 2024
The undruggable cancer target: KRAS inhibitors move ahead in the clinic
Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout.
Best in Biotech 21 May 2024
Eight companies spearheading Philadelphia’s biotech industry
Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.
Powering up biologics development using mammalian cell lines
Explore how mammalian cell lines drive biopharmaceutical innovation, acting as mini-factories for vital biotherapeutics and vaccines.
Inside Labiotech 20 May 2024
Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card!
We would like to learn more about you. Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card!
ADVERTISEMENT
